Laguna Bio is developing next-generation cancer immunotherapy using its QUAIL platform, which is based on food-borne microbes modified to be harmless while retaining the ability to provoke a large and durable immune response. The activated immune cells generated by QUAIL can be directed to attack tumors alone or in combination with other immunotherapies that provide tumor-specific targeting, including bispecific antibodies.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account